The reiteration of a Buy rating and maintenance of a $50 price target by a reputable analyst firm like HC Wainwright & Co. could instill confidence in investors and potentially lead to a positive short term impact on Calliditas Therapeutics' stock price. Analyst ratings, especially those accompanied by optimistic price targets, can influence market perception and investor sentiment.